222
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Alteration of NF-κB activity leads to mitochondrial apoptosis after infection with pathological prion protein

      research-article

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Nuclear factor kappa B (NF-κB) is a key regulator of the immune response, but in almost the same manner it is involved in induction of inflammation, proliferation and regulation of apoptosis. In the central nervous system activated NF-κB plays a neuroprotective role. While in some neurodegenerative disorders the role of NF-κB is well characterized, there is poor knowledge on the role of NF-κB in prion disease. We found binding but no transcriptional activity of the transcription factor in vitro. Characterizing the mechanism of cell death after infection with pathological prion protein increased caspase-9 and caspase-3 activity was detected and the lack of NF-κB activity resulted in the inability to activate target genes that usually play an important role in neuroprotection. Additionally, we investigated the role of NF-κB after prion infection of Nfkb1 –/–, Nfkb2 –/– and Bcl3 –/– mice and central nervous system-specific p65-deleted mice revealing an accelerated prion disease in NF-κB2- and Bcl-3-deficient mice, which is in line with a reduced neuroprotective activity in prion infection. Based on our findings, we propose a model whereby the alteration of NF-κB activity at the early stages of infection with pathological prion protein leads to neuronal cell death mediated by mitochondrial apoptosis.

          Related collections

          Most cited references41

          • Record: found
          • Abstract: not found
          • Article: not found

          The proto-oncogene Bcl-2 and its role in regulating apoptosis.

          G Kroemer (1997)
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Depleting neuronal PrP in prion infection prevents disease and reverses spongiosis.

            The mechanisms involved in prion neurotoxicity are unclear, and therapies preventing accumulation of PrPSc, the disease-associated form of prion protein (PrP), do not significantly prolong survival in mice with central nervous system prion infection. We found that depleting endogenous neuronal PrPc in mice with established neuroinvasive prion infection reversed early spongiform change and prevented neuronal loss and progression to clinical disease. This occurred despite the accumulation of extraneuronal PrPSc to levels seen in terminally ill wild-type animals. Thus, the propagation of nonneuronal PrPSc is not pathogenic, but arresting the continued conversion of PrPc to PrPSc within neurons during scrapie infection prevents prion neurotoxicity.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation.

              In Alzheimer disease (AD) the amyloid beta-peptide (A beta) accumulates in plaques in the brain. A beta can be neurotoxic by a mechanism involving induction of reactive oxygen species (ROS) and elevation of intracellular free calcium levels ([Ca2+]i). In light of evidence for an inflammatory response in the brain in AD and reports of increased levels of tumor necrosis factor (TNF) in AD brain we tested the hypothesis that TNFs affect neuronal vulnerability to A beta. A beta-(25-35) and A beta-(1-40) induced neuronal degeneration in a concentration- and time-dependent manner. Pretreatment of cultures for 24 hr with TNF-beta or TNF-alpha resulted in significant attenuation of A beta-induced neuronal degeneration. Accumulation of peroxides induced in neurons by A beta was significantly attenuated in TNF-pretreated cultures, and TNFs protected neurons against iron toxicity, suggesting that TNFs induce antioxidant pathways. The [Ca2+]i response to glutamate (quantified by fura-2 imaging) was markedly potentiated in neurons exposed to A beta, and this action of A beta was suppressed in cultures pretreated with TNFs. Electrophoretic mobility-shift assays demonstrated an induction of a kappa beta-binding activity in hippocampal cells exposed to TNFs. Exposure of cultures to I kappa B (MAD3) antisense oligonucleotides, a manipulation designed to induce NF-kappa B, mimicked the protection by TNFs. These data suggest that TNFs protect hippocampal neurons against A beta toxicity by suppressing accumulation of ROS and Ca2+ and that kappa B-dependent transcription is sufficient to mediate these effects. A modulatory role for TNF in the neurodegenerative process in AD is proposed.
                Bookmark

                Author and article information

                Journal
                Cell Microbiol
                cmi
                Cellular Microbiology
                Blackwell Publishing Ltd
                1462-5814
                1462-5822
                September 2007
                15 June 2007
                : 9
                : 9
                : 2202-2217
                Affiliations
                [1 ]Friedrich-Loeffler-Institut, Federal Research Institute for Animals Health, Institute of Immunology Tübingen Germany
                [2 ]Department of Immunology, Institute for Cell Biology, Eberhard-Karls-University Tübingen Germany
                [3 ]Department of Internal Medicine II, Technical University Munich, Germany
                Author notes
                *For correspondence. E-mail oliver.planz@ 123456fli.bund.de ; Tel. (+49) 7071 967 254; Fax (+49) 7071 967 105.
                [†]

                Present addresses: Department of Neurology, Molecular Neurology Unit, University of Muenster, Mendelstrasse 7, D-48149 Muenster, Germany

                [‡]

                Fritz Lipmann Institute, Leibniz Institute for Age Research, Beutenbergstrasse 11, D-07745 Jena, Germany.

                Re-use of this article is permitted in accordance with the Creative Commons Deed, Attribution 2.5, which does not permit commercial exploitation.

                Article
                10.1111/j.1462-5822.2007.00950.x
                2048569
                17573907
                a525f45a-ddb0-40cb-87d3-9652fe01a256
                © 2007 The Authors; Journal compilation © 2007 Blackwell Publishing Ltd
                History
                : 11 January 2007
                : 05 March 2007
                : 26 March 2007
                Categories
                Original Articles

                Microbiology & Virology
                Microbiology & Virology

                Comments

                Comment on this article